A comparison of the rapid-acting insulin analogue glulisine with lispro and aspart for the pump treatment of patients with type 1 diabetes

Bramlage, P; Tittel, SR; Muther, S; Reinhart-Steininger, B; Haberland, H; Khodaverdi, S; Zimny, S; Ohlenschlager, U; Lanzinger, S; Haak, T

Bramlage, P (通讯作者)，Inst Pharmakol & Pravent Med, Bahnhofstr 20, D-49661 Cloppenburg, Germany.

ACTA DIABETOLOGICA, 2022; 59 (11): 1453

Abstract

Aims (1) To describe the population of patients with type 1 diabetes (T1DM) using the rapid-acting insulin analogue glulisine versus lispro and aspart......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索